Intelligence Β· Patent portfolio
Takeda Patents
Full USPTO pharma patent portfolio for Takeda β grant dates, expiration, and drug cross-links.
- Patents
- 1,436
- Expiring β€24m
- 81
Quick answer
Takeda has 1,436 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 81 expire within 24 months β use filters for patent-cliff planning.
-
US 9878989
Heterocyclic compound
granted -
US 9868725
Isoindoline-1-one derivatives as cholinergic muscarinic M1 receptor positive alloesteric modulator activity for the treatment of Alzheimer's disease
granted -
US 9867876
Parenteral norovirus vaccine formulations
granted -
US 9861691
Norovirus vaccine formulations
granted -
US 9856310
UTI fusion proteins
granted -
US 9834520
Heterocyclic compound
granted -
US 9833410
Lyophilized formulation comprising GM-CSF neutralizing compound
granted -
US 9834757
Hand, foot, and mouth vaccines and methods of manufacture and use thereof
granted -
US 9828357
Cyclic compounds
granted -
US 9827255
Fumagillol derivatives
granted -
US 9821049
Method of conferring a protective immune response to Norovirus
granted -
US 9815938
Production method for poly(amino acid)
granted -
US 9814686
Rolled collagen carrier
granted -
US 9809569
Process for producing heterocyclic compound
granted -
US 9801907
Film-coated and/or granulated calcium-containing compounds and use therof in pharmaceutical compositions
granted -
US 9801872
Pyridinyl and fused pyridinyl triazolone derivatives
granted -
US 9801934
Parenteral norovirus vaccine formulations
granted -
US 9790285
Anti-CD38 antibodies
granted -
US 9789084
Nitrogen-containing heterocyclic compound
granted -
US 9789083
Nitrogen-containing heterocyclic compound
granted -
US 9790201
Piperidine and azepine derivatives as prokineticin receptor modulators
granted -
US 9790220
Substituted cyclopentanes, tetrahydrofuranes and pyrrolidines as orexin receptor antagonists
granted -
US 9776962
Aromatic compounds with GPR40 agonistic activity
granted -
US 9775827
Nitrogen-containing heterocyclic compound
granted -
US 9777005
Bicyclic heterocyclic compound containing a substituted pyrrole ring
granted -
US 9770450
4-OXO-3,4-dihydro-1,2,3-benzotriazine as modulators of GPR139
granted -
US 9770452
Quinoxaline derivatives as GPR6 modulators
granted -
US 9757377
Solid preparation
granted -
US 9750748
Pyridazinones as DAAO enzyme inhibitors
granted -
US 9751878
Tetrahydronaphthyridine somatostatin receptor 5 antagonists
granted -
US 9751885
Cyclopropanamine compound and use thereof
granted -
US 9745325
Fused heterocyclic compound
granted -
US 9724339
Methods and drug products for treating alzheimer's disease
granted -
US 9718814
Cyclopropanamine compound and use thereof
granted -
US 9713595
Sustained-release composition and method for producing the same
granted -
US 9714241
Cyclopropanamine compound and use thereof
granted -
US 9713638
Compositions and methods for rapid immunization against dengue virus
granted -
US 9708313
Substituted pyrido[3,4-b]pyrazines as GPR6 modulators
granted -
US 9708296
6-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD
granted -
US 9701623
Di-aliphatic substituted pegylated lipids
granted -
US 9695195
5-HT3 receptor antagonists
granted -
US 9693962
Dry-coated tablet
granted -
US 9682925
Cyclopropaneamine compound
granted -
US 9676869
Conjugated anti-CD38 antibodies
granted -
US 9675597
Nitrogen-containing heterocyclic compound
granted -
US 9670229
5-HT3 receptor antagonists
granted -
US 9662316
Nitrogen-containing heterocyclic compound
granted -
US 9663514
Substituted 6-aza-isoindolin-1-one derivatives
granted
Frequently asked questions
How many patents does Takeda have?
1,436 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Takeda patents expire?
81 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.
Where does this data come from?
USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.
Data attribution: Data sources Β· Patent directory